AMEX:MRIC

Stock Analysis Report

Executive Summary

MRI Interventions, Inc. operates as a medical device company primarily in the United States.

Snowflake

Fundamentals

Flawless balance sheet with weak fundamentals.

Risks

  • MRI Interventions has significant price volatility in the past 3 months.
  • MRI Interventions is not covered by any analysts.

Similar Companies

Share Price & News

How has MRI Interventions's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

19.7%

AMEX:MRIC

-1.2%

US Medical Equipment

1.2%

US Market


1 Year Return

242.9%

AMEX:MRIC

8.7%

US Medical Equipment

1.7%

US Market

MRIC outperformed the Medical Equipment industry which returned 8.7% over the past year.

MRIC outperformed the Market in United States of America which returned 1.7% over the past year.


Share holder returns

MRICIndustryMarket
7 Day19.7%-1.2%1.2%
30 Day37.1%1.4%4.9%
90 Day50.5%4.8%3.7%
1 Year242.9%242.9%9.6%8.7%3.9%1.7%
3 Year-26.2%-26.2%70.8%65.5%47.2%37.7%
5 Year-89.9%-89.9%130.4%104.1%60.0%42.4%

Price Volatility Vs. Market

How volatile is MRI Interventions's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is MRI Interventions undervalued based on future cash flows and its price relative to the stock market?

9.51x

Price to Book (PB) ratio


Intrinsic Value Based on Future Cash Flows

Unable to calculate intrinsic value for MRI Interventions to establish if it is available at moderate discount.

Unable to calculate intrinsic value for MRI Interventions to establish if it is available at substantial discount.


Price Based on Earnings

MRI Interventions is loss making, we can't compare its value to the US Medical Equipment industry average.

MRI Interventions is loss making, we can't compare the value of its earnings to the United States of America market.


Price Based on Expected Growth

Unable to calculate PEG ratio for MRI Interventions, we can't assess if its growth is good value.


Price Based on Value of Assets

MRI Interventions is overvalued based on assets compared to the US Medical Equipment industry average.


Next Steps

Future Growth

How is MRI Interventions expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

22.6%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as MRI Interventions has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has MRI Interventions performed over the past 5 years?

2.2%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

MRI Interventions does not make a profit even though their year on year earnings growth rate was positive over the past 5 years.

Unable to compare MRI Interventions's 1-year earnings growth to the 5-year average as it is not currently profitable.

Unable to compare MRI Interventions's 1-year growth to the US Medical Equipment industry average as it is not currently profitable.


Return on Equity

It is difficult to establish if MRI Interventions has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.


Return on Assets

It is difficult to establish if MRI Interventions has efficiently used its assets last year compared to the US Medical Equipment industry average (Return on Assets) as it is loss-making.


Return on Capital Employed

It is difficult to establish if MRI Interventions improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.


Next Steps

Financial Health

How is MRI Interventions's financial position?


Financial Position Analysis

MRI Interventions is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.

MRI Interventions's cash and other short term assets cover its long term commitments.


Debt to Equity History and Analysis

MRI Interventions's level of debt (27.1%) compared to net worth is satisfactory (less than 40%).

MRI Interventions had negative shareholder equity 5 years ago, it is now positive therefore their debt level has improved.


Balance Sheet

High level of physical assets or inventory.

Debt is covered by short term assets, assets are 6.3x debt.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

MRI Interventions has sufficient cash runway for 2.4 years based on current free cash flow.

MRI Interventions has sufficient cash runway for 1.9 years if free cash flow continues to reduce at historical rates of -13.5% each year.


Next Steps

Dividend

What is MRI Interventions's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate MRI Interventions's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate MRI Interventions's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as MRI Interventions has not reported any payouts.

Unable to verify if MRI Interventions's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as MRI Interventions has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of MRI Interventions's salary, the management and board of directors tenure and is there insider trading?

3.1yrs

Average management tenure


CEO

Joe Burnett (42yo)

1.8yrs

Tenure

US$515,249

Compensation

Mr. Joseph Michael Burnett, also known as Joe, has been Chief Executive Officer, President and Director of MRI Interventions, Inc. since November 7, 2017. Mr. Burnett has spent his entire career in medical ...


CEO Compensation Analysis

Joe's remuneration is about average for companies of similar size in United States of America.

Joe's compensation has been consistent with company performance over the past year, both up more than 20%.


Management Age and Tenure

3.1yrs

Average Tenure

58.5yo

Average Age

The tenure for the MRI Interventions management team is about average.


Board Age and Tenure

5.3yrs

Average Tenure

60yo

Average Age

The tenure for the MRI Interventions board of directors is about average.


Insider Trading

No 3 month open market individual insider trading information.


Recent Insider Transactions

BuyUS$4,000,00124 May 19
PTC Therapeutics, Inc.
EntityCompany
Shares1,290,323
Max PriceUS$3.10
BuyUS$31,25025 Sep 18
Joseph Burnett
EntityIndividual
Role
Chief Executive Officer
President
Shares25,000
Max PriceUS$1.25

Ownership Breakdown


Management Team

  • Hal Hurwitz (67yo)

    CFO & Corporate Secretary

    • Tenure: 4.3yrs
    • Compensation: US$284.65k
  • Paul Bottomley (66yo)

    • Tenure: 0yrs
    • Compensation: US$4.33k
  • Kimble Jenkins (57yo)

    Executive Chairman

    • Tenure: 16.7yrs
    • Compensation: US$67.53k
  • Frank Grillo (57yo)

    Executive Advisor

    • Tenure: 1.8yrs
    • Compensation: US$710.52k
  • Peter Piferi (60yo)

    Chief Operating Officer

    • Tenure: 12.8yrs
    • Compensation: US$305.72k
  • Joe Burnett (42yo)

    President

    • Tenure: 1.8yrs
    • Compensation: US$515.25k

Board Members

  • R. Fletcher (73yo)

    Lead Independent Director

    • Tenure: 0yrs
    • Compensation: US$64.90k
  • B. Johnson (67yo)

    Director

    • Tenure: 0yrs
  • Jack Spencer (78yo)

    Director

    • Tenure: 9.5yrs
    • Compensation: US$72.53k
  • Kimble Jenkins (57yo)

    Executive Chairman

    • Tenure: 16.7yrs
    • Compensation: US$67.53k
  • Pascal E. Girin (59yo)

    Director

    • Tenure: 5yrs
    • Compensation: US$65.03k
  • Tim Richards (61yo)

    Director

    • Tenure: 5.5yrs
    • Compensation: US$65.53k
  • Joe Burnett (42yo)

    President

    • Tenure: 1.8yrs
    • Compensation: US$515.25k
  • Marcio Souza (40yo)

    Director

    • Tenure: 0.3yrs

Company Information

MRI Interventions, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: MRI Interventions, Inc.
  • Ticker: MRIC
  • Exchange: AMEX
  • Founded: 1998
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: US$67.191m
  • Shares outstanding: 14.00m
  • Website: https://www.mriinterventions.com

Number of Employees


Location

  • MRI Interventions, Inc.
  • 5 Musick
  • Irvine
  • California
  • 92618
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
MRICAMEX (NYSE MKT LLC)YesCommon StockUSUSDMay 2012

Biography

MRI Interventions, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the b ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/15 00:19
End of Day Share Price2019/09/13 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.